| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $109.2M | — | — |
| R&D Expense | $12K | -100.0% | -100.0% |
| SG&A Expense | $6.8M | -12.4% | -18.2% |
| Operating Income | -$36.1M | -4.2% | -3.8% |
| Pre-tax Income | -$34.4M | -5.8% | -10.2% |
| Income Tax | -$8K | — | +0.0% |
| Net Income | -$34.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $55.5M | -2.4% | +5.6% |
| Short-term Investments | $77.2M | -22.0% | -46.9% |
| Current Assets | $137.7M | -14.0% | -33.2% |
| Total Assets | $244.7M | -14.0% | -37.0% |
| Current Liabilities | $22.0M | +47.4% | +11.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$87.8M | — | — |
| Capital Expenditures | $987K | — | — |
| Investing Cash Flow | $85.1M | — | — |
| Financing Cash Flow | $120K | — | — |
| Free Cash Flow | -$88.8M | — | — |
| -10.2% |
| EPS (Basic) | -$0.40 | -5.3% | -8.1% |
| EPS (Diluted) | -$0.40 | -5.3% | -8.1% |
| $68.4M |
| -8.6% |
| -64.6% |
| Stockholders' Equity | $176.3M | -16.0% | -9.9% |